From the analysis of the K-M curve, it could also be seen that there was no significant difference in PFS and OS between MM patients with serum IL-17A > 0.1 and MM patients with IL-17A ≤ 0.1 (Figures 4A, B). Here, IL17A is linked to Miyoshi myopathy.